Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)

China flag China · Delayed Price · Currency is CNY
74.50
+10.40 (16.22%)
At close: Feb 27, 2026
Market Cap5.88B +305.8%
Revenue (ttm)177.11M -38.6%
Net Income-125.32M
EPS-1.61
Shares Out78.96M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,750,486
Average Volume1,056,436
Open64.13
Previous Close64.10
Day's Range63.35 - 74.99
52-Week Range19.00 - 74.50
Beta0.19
RSI76.10
Earnings DateApr 29, 2026

About SHE:301075

Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, intermediates, and raw materials in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as sodium acetate ringer's injection; and agent products, such as amoxicillin sodium and clavulanate potassium for injection, etc. The company was founded in 2005 and is headquartered in Tibet, China. [Read more]

Sector Healthcare
Founded 2005
Employees 497
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301075
Full Company Profile

Financial Performance

Financial Statements